This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2015 Aug;14(8):780-781.

doi: 10.1016/S1474-4422(15)00143-X. Epub 2015 Jun 23.

Neuroprotection in Parkinson's disease: a difficult challenge

Fabrizio Stocchi¹

Affiliations

PMID: 26116314
DOI: 10.1016/S1474-4422(15)00143-X

Comment

Neuroprotection in Parkinson's disease: a difficult challenge

Fabrizio Stocchi. Lancet Neurol. 2015 Aug.

. 2015 Aug;14(8):780-781.

doi: 10.1016/S1474-4422(15)00143-X. Epub 2015 Jun 23.

Author

Fabrizio Stocchi¹

Affiliation

¹ Institute for Research and Medical Care IRCCS San Raffaele, via della Pisana 235, 00163 Rome, Italy. Electronic address: fabrizio.stocchi@fastwebnet.it.

PMID: 26116314
DOI: 10.1016/S1474-4422(15)00143-X

No abstract available

PubMed Disclaimer

Comment on

Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial.
NINDS Exploratory Trials in Parkinson Disease (NET-PD) FS-ZONE Investigators. NINDS Exploratory Trials in Parkinson Disease (NET-PD) FS-ZONE Investigators. Lancet Neurol. 2015 Aug;14(8):795-803. doi: 10.1016/S1474-4422(15)00144-1. Epub 2015 Jun 23. Lancet Neurol. 2015. PMID: 26116315 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information